2025 Public Policy Comments

• • January 18, 2025 – OAC comments on CMS Proposed Rule Coverage for Obesity Medications
  • January 23, 2025 – OCAN comments on CMS Part D Rule CMS-4208-P
  • January 27, 2025 – Indiana: OAC supports HB 1202 Medicaid coverage for treatment of obesity
  • January 28, 2025 – North Dakota: OAC supports House Bills 1451 and 1452
  • February 6, 2025 – OAC joins the Alliance for Women’s Health and Prevention and others to call for an Employer Pledge for Obesity Care
  • February 12, 2025 – Virginia: OAC Supports Medicaid Coverage of FDA-Approved Obesity Medications
  • February 18, 2025 – OAC Comments on FL Compounding Code Update
  • February 18, 2025 – Letter to Connecticut Governor: Obesity Care Coverage under Budget Proposal
  • February 20, 2025 – OAC Comments on CA BoP Compounding Code Update
  • March 3, 2025 – OAC Supports MD Medical Assistance Program – Coverage for the Treatment of Obesity
  • March 6, 2025 – OAC Comments on NCD Quarterly Meeting
  • March 11, 2025 – OAC Statement of Support for CO SB25-048: Diabetes Prevention and Obesity Treatment Act
  • March 12, 2025 – Obesity Groups Comment on CT DSS SPA-0014: Pharmacy Obesity Weight Loss Drug Coverage
  • March 17, 2025 – OAC Statement of Support for NV AB 399: Insurance Coverage for Treatment of Severe Obesity
  • March 17, 2025 – OAC Statement of Support for NY S.3104/ A.4211: Comprehensive Obesity Treatment Health Insurance Coverage
  • March 18, 2025 – OAC Comments on PA Budget Proposal
  • March 20, 2025 – OAC and TOS Acknowledge FDA Declaration that Wegovy and Ozempic Shortage Has Been Resolved
  • March 20, 2025 – OAC Statement of Support for ME LD627: Insurance Coverage for Glucagon-like Peptide-1 Receptor Agonist Medication
  • March 20, 2025 – OAC Statement of Support for NV SB 244: Medicaid Coverage for Diabetes Prevention and Obesity Treatment
  • March 25, 2025 – OAC Statement of Support for AR HB 1424: Insurance Coverage for Treatment of Severe Obesity
  • March 25, 2025 – Obesity Groups Support Passage of MD HB 1489: Expand Medical Coverage of Comprehensive Obesity Care
  • March 26, 2025 – Obesity Groups Support Passage of MN Obesity Bill
  • March 28, 2025 – Obesity Groups Applaud CO HCPF Reconsideration of Medicaid Regulations Governing Coverage of Metabolic and Bariatric Surgery
  • April 3, 2025 – OAC Comments on FDA-2007-D-0435
  • April 3, 2025 – Letter to Trump Administration Urging Support for CMS Coverage 
  • April 25, 2025 – Leading Patient Groups Submit Recommendations for Inclusion in the Proposed Rule Updating the Medicare Physician Fee Schedule for Calendar Year 2026
  • May 5, 2025 – Obesity Groups Oppose PA Medicaid Proposed Requirements for Prior Authorization of FDA-Approved Obesity Medications
  • May 8, 2025 – SB25-048 Senate Bill – Diabetes Prevention and Obesity Treatment Act
  • May 13, 2025 – Letter to PA Governor on Obesity Treatments
  • May 14, 2025 – OAC Statement of Record on HHS Budget
  • May 15, 2025 – OAC Urges OR PEBB to Include FDA-Approved OMs in Health Plan Renewals
  • May 19, 2025 – OAC Commends ICER for Recognizing Obesity as a Chronic Disease
  • May 20, 2025 – OAC Supports Rhode Island HB 6254
  • May 29, 2025 – Ohio: OAC, ADA Urge Department of Medicaid to Remove Prohibition Against OM Coverage
  • May 30, 2025 – Obesity Groups Oppose Elimination of Medical Coverage of GLP-1 OMs in CA Budget Proposal
  • May 30, 2025 – Ohio: OAC Urges Expanded Access to OM Coverage
  • June 17, 2025 – OAC Strongly Opposes DAS Decision to Discontinue Coverage of GLP-1 as Part of the OSEHP
  • June 17, 2025 – OAC Shares Concern over 2026 Proposed HHS Budget with U.S. House of Representatives
  • June 24, 2025 – Obesity Groups Support Medicaid Coverage of OMs in NJ Budget
  • June 24, 2025 – OCAN Urges HHS Secretary Kennedy to Support Obesity Prevention, Treatment and Research Programs
  • July 10, 2025 – Obesity Groups Support Medical Coverage for Obesity Medications & Treatment in NY
  • August 15, 2025 – SB 535 Group Letter of Support
  • August 18, 2025 – Thank You Letter to Deputy Commissioner Director of TennCare
  • August 20, 2025 – Ohio: OAC Sends Sign-on Letter to Gov. DeWine Regarding Obesity Coverage
  • August 22, 2025 – OAC Thank You Letter to OMB for CDC Funding
  • August 28, 2025 – Obesity Groups Urge TRICARE to Continue Access to FDA-Approved GLP-1 Medications for Obesity
  • September 4, 2025 – Obesity Groups Urge CMS Administrator OZ to Include Access to Evidence-based Obesity Treatments for Medicare Recipients
  • September 11, 2025 – Obesity Groups Urge PA’s P&T Committee Not to Change Eligibility Criteria for Prior Authorization of GLP-1s Used to Treat Obesity
  • September 12, 2025 – Obesity Groups Comment on Proposed Medicare Physician Fee Schedule for Calendar Year 2026
  • October 21, 2025 – Obesity Patient Group Recommends WI Group Insurance Board to Update and Establish Obesity Medication Coverage for State Employees
  • October 21, 2025 – OAC Urges DOW to Allow TRICARE Coverage of Obesity Medications for Beneficiaries
  • November 3, 2025 – Obesity Groups Urge Congressional Leaders to Restore Funding for Vital Health and Nutrition Programs
  • November 7, 2025 – OAC Comments on KY Department of Medicaid Services Proposed Amendment to Remove Outdated Language Prohibiting Medicaid Coverage of OMs
  • November 12, 2025 – OAC Urges AL Chronic Weight Management and Type 2 Diabetes Task Force to Support SEHP and Medicaid Coverage of OMs
  • November 14, 2025 – OAC Letter of Support for New ICS-10-CM for Hepatic Fibrosis
  • December 8, 2025 – Obesity Groups Comment on NV Medicaid Coverage for Obesity Medications and Treatment
  • December 9, 2025 – OCAN Letter to Dr. Oz re: Expansion of OMs in Medicare and Medicaid